JP7389748B2 - フィトステノンの新規用途 - Google Patents
フィトステノンの新規用途 Download PDFInfo
- Publication number
- JP7389748B2 JP7389748B2 JP2020539568A JP2020539568A JP7389748B2 JP 7389748 B2 JP7389748 B2 JP 7389748B2 JP 2020539568 A JP2020539568 A JP 2020539568A JP 2020539568 A JP2020539568 A JP 2020539568A JP 7389748 B2 JP7389748 B2 JP 7389748B2
- Authority
- JP
- Japan
- Prior art keywords
- phytostenone
- fat
- subcutaneous fat
- phytosterol
- ene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000004003 subcutaneous fat Anatomy 0.000 claims description 42
- 239000003795 chemical substances by application Substances 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 28
- 239000000203 mixture Substances 0.000 claims description 28
- 238000010521 absorption reaction Methods 0.000 claims description 25
- ATIPVUGMJZAJPC-IMUDCKKOSA-N (8s,9s,10r,13r,14s,17r)-17-[(2r,5r)-5,6-dimethylheptan-2-yl]-10,13-dimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one Chemical group C1C=C2CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 ATIPVUGMJZAJPC-IMUDCKKOSA-N 0.000 claims description 20
- 239000002537 cosmetic Substances 0.000 claims description 11
- 230000009467 reduction Effects 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- -1 cytost-5-en-3-one Chemical compound 0.000 description 13
- 229940068065 phytosterols Drugs 0.000 description 13
- 244000005700 microbiome Species 0.000 description 10
- 210000001596 intra-abdominal fat Anatomy 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- UVFOCYGYACXLAY-ZDQUCUCBSA-N Stigmast-4-ene-3,6-dione Chemical compound C1C(=O)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 UVFOCYGYACXLAY-ZDQUCUCBSA-N 0.000 description 6
- 238000009825 accumulation Methods 0.000 description 6
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 5
- 239000006071 cream Substances 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000004060 metabolic process Effects 0.000 description 5
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 5
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 4
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 210000000577 adipose tissue Anatomy 0.000 description 4
- 235000000431 campesterol Nutrition 0.000 description 4
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 125000002328 sterol group Chemical group 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- UVFOCYGYACXLAY-UHFFFAOYSA-N (24R)-24-ethylcholest-4-en-3,6-dione Natural products C1C(=O)C2=CC(=O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 UVFOCYGYACXLAY-UHFFFAOYSA-N 0.000 description 3
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 3
- OILXMJHPFNGGTO-NRHJOKMGSA-N Brassicasterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@](C)([C@H]([C@@H](/C=C/[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 OILXMJHPFNGGTO-NRHJOKMGSA-N 0.000 description 3
- 108010089254 Cholesterol oxidase Proteins 0.000 description 3
- 208000008589 Obesity Diseases 0.000 description 3
- 229930182558 Sterol Natural products 0.000 description 3
- OILXMJHPFNGGTO-ZRUUVFCLSA-N UNPD197407 Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)C=C[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZRUUVFCLSA-N 0.000 description 3
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 3
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 3
- 235000004420 brassicasterol Nutrition 0.000 description 3
- OILXMJHPFNGGTO-ZAUYPBDWSA-N brassicasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZAUYPBDWSA-N 0.000 description 3
- QQIOPZFVTIHASB-IMUDCKKOSA-N campest-4-en-3-one Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 QQIOPZFVTIHASB-IMUDCKKOSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- QQIOPZFVTIHASB-UHFFFAOYSA-N ergost-4-en-3-one Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C(C)CCC(C)C(C)C)C1(C)CC2 QQIOPZFVTIHASB-UHFFFAOYSA-N 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- 206010033675 panniculitis Diseases 0.000 description 3
- 235000002378 plant sterols Nutrition 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 3
- 229950005143 sitosterol Drugs 0.000 description 3
- 150000003432 sterols Chemical class 0.000 description 3
- 235000003702 sterols Nutrition 0.000 description 3
- QHFXYKPFTMVXFI-UHFFFAOYSA-N stigmast-4-ene-3,6-dione Natural products CCC(CCC(C)C1CCC2(C)C1CCC3C2CC(=O)C4=CC(=O)CCC34C)C(C)C QHFXYKPFTMVXFI-UHFFFAOYSA-N 0.000 description 3
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 3
- 235000016831 stigmasterol Nutrition 0.000 description 3
- 229940032091 stigmasterol Drugs 0.000 description 3
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 3
- 210000004304 subcutaneous tissue Anatomy 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 2
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 2
- KYOFIJXMVNQYFC-XJZKHKOHSA-N (8s,9s,10r,13r,14s,17r)-17-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-1,2,4,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one Chemical compound C1C=C2CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KYOFIJXMVNQYFC-XJZKHKOHSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 2
- 241000186146 Brevibacterium Species 0.000 description 2
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 2
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 2
- MKGZDUKUQPPHFM-UHFFFAOYSA-N Delta4-Stigmastenon Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 MKGZDUKUQPPHFM-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- PLUBXMRUUVWRLT-UHFFFAOYSA-N Ethyl methanesulfonate Chemical compound CCOS(C)(=O)=O PLUBXMRUUVWRLT-UHFFFAOYSA-N 0.000 description 2
- 241000203720 Pimelobacter simplex Species 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 2
- RUVUHIUYGJBLGI-XJZKHKOHSA-N beta-sitostenone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 RUVUHIUYGJBLGI-XJZKHKOHSA-N 0.000 description 2
- KYOFIJXMVNQYFC-UHFFFAOYSA-N beta-sitostenone Natural products C1C=C2CC(=O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 KYOFIJXMVNQYFC-UHFFFAOYSA-N 0.000 description 2
- 238000010170 biological method Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 235000015500 sitosterol Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- GWOSBUGZGFVDDS-LKGWFGLDSA-N (8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,7,8,9,11,12,14,15,16,17-decahydro-1h-cyclopenta[a]phenanthrene-3,6-dione Chemical compound C1C(=O)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 GWOSBUGZGFVDDS-LKGWFGLDSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- WTLKTXIHIHFSGU-UHFFFAOYSA-N 2-nitrosoguanidine Chemical class NC(N)=NN=O WTLKTXIHIHFSGU-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- 241000222518 Agaricus Species 0.000 description 1
- 241000186063 Arthrobacter Species 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 240000000950 Hippophae rhamnoides Species 0.000 description 1
- 235000003145 Hippophae rhamnoides Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000228347 Monascus <ascomycete fungus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- VZUNGTLZRAYYDE-UHFFFAOYSA-N N-methyl-N'-nitro-N-nitrosoguanidine Chemical class O=NN(C)C(=N)N[N+]([O-])=O VZUNGTLZRAYYDE-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229940123973 Oxygen scavenger Drugs 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000316848 Rhodococcus <scale insect> Species 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 238000006859 Swern oxidation reaction Methods 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 241000222355 Trametes versicolor Species 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 150000008378 aryl ethers Chemical class 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 210000000028 corpus adiposum pararenale Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000013367 dietary fats Nutrition 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- DENRZWYUOJLTMF-UHFFFAOYSA-N diethyl sulfate Chemical compound CCOS(=O)(=O)OCC DENRZWYUOJLTMF-UHFFFAOYSA-N 0.000 description 1
- 229940008406 diethyl sulfate Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000004136 fatty acid synthesis Effects 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000000713 mesentery Anatomy 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 125000004043 oxo group Chemical group O=* 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000012521 purified sample Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- RUVUHIUYGJBLGI-UHFFFAOYSA-N stigmast-4-en-3-one Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 RUVUHIUYGJBLGI-UHFFFAOYSA-N 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Child & Adolescent Psychology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Birds (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Steroid Compounds (AREA)
Description
すなわち、以下に示す、経皮吸収剤などが提供される。
[1-2] フィトステノンは、フィトステノン含有組成物である、上記[1-1]に記載の経皮吸収剤。
[1-3] フィトステノン含有組成物は、フィトステロールの5-エン-3-オン体、フィトステロールの4-エン-3-オン体、およびフィトステロールの4-エン-3,6-ジオン体を含む、上記[1-2]に記載の経皮吸収剤。
[1-4] フィトステノンはカンペスト-5-エン-3-オンである、上記[1-1]に記載の経皮吸収剤。
[1-5] 化粧料である、上記[1-1]~[1-4]のいずれか1項に記載の経皮吸収剤。
[1-6] 医薬である、上記[1-1]~[1-4]のいずれか1項に記載の経皮吸収剤。
[2-2] フィトステノンは、フィトステノン含有組成物である、上記[2-1]に記載のフィトステノン。
[2-3] フィトステノン含有組成物は、フィトステロールの5-エン-3-オン体、フィトステロールの4-エン-3-オン体、およびフィトステロールの4-エン-3,6-ジオン体を含む、上記[2-3]に記載のフィトステノン。
[2-4] フィトステノンはカンペスト-5-エン-3-オンである、上記[2-1]に記載のフィトステノン。
[2-5] 化粧料として用いるための、上記[2-1]~[2-4]のいずれか1項に記載のフィトステノン。
[2-6] 医薬として用いるための、上記[2-1]~[2-4]のいずれか1項に記載のフィトステノン。
[3-2] フィトステノンは、フィトステノン含有組成物である、上記[3-1]に記載の方法。
[3-3] フィトステノン含有組成物は、フィトステロールの5-エン-3-オン体、フィトステロールの4-エン-3-オン体、およびフィトステロールの4-エン-3,6-ジオン体を含む、上記[3-2]に記載の方法。
[3-4] フィトステノンはカンペスト-5-エン-3-オンである、上記[3-1]に記載の方法。
[3-5] 化粧方法である、上記[3-1]~[3-4]のいずれか1項に記載の方法。
[3-6] 治療方法である、上記[3-1]~[3-4]のいずれか1項に記載の方法。
好ましい態様の経皮吸収剤は、対象の皮膚に適用することで、対象の皮下脂肪を低減することができる。別の好ましい態様の経皮吸収剤は、対象の皮膚に適用することで、対象の皮下に過剰に蓄積された脂肪を代謝低減することができる。さらに別の好ましい態様の経皮吸収剤は、対象の皮下に局所的または広範囲に過剰蓄積され、健康または美容の観点から問題のある脂肪を低減することができ、対象の健康または美容を改善することができる。
いくつかの態様は、フィトステノンを含有する、皮下脂肪を低減するための経皮吸収剤を提供する。フィトステノンは、1種単独で使用してもよく、あるいは2種以上を組み合わせて使用してもよい。
被験物質であるフィトステノン含有組成物は特開2007-284348号公報に記載の発酵法に準ずる方法によって製造した。具体的には、あらかじめフィトステロールを含む培地でグラム陽性菌を培養し、培養液を調製した。調製した培養液にフィトステロールを添加し、さらに有機溶媒を重層した後、撹拌翼で強く撹拌した。その後、二層分離により上層を回収し、乾固させて、フィトステノン含有組成物を得た。得られたフィトステノン含有組成物には50重量%以上の各種ステノン類が含まれていた。
ここで、「フィトスト-4-エン-3,6-ジオン」は、カンペスト-4-エン-3,6-ジオン、シトスト-4-エン-3,6-ジオン、スティグマスト-4-エン-3,6-ジオン、およびブラシカスト-4-エン-3,6-ジオンの混合物である。
Claims (8)
- フィトステノンを含有する、皮下脂肪を低減するための経皮吸収剤。
- フィトステノンは、フィトステノン含有組成物である、請求項1に記載の経皮吸収剤。
- フィトステノン含有組成物は、フィトステロールの5-エン-3-オン体、フィトステロールの4-エン-3-オン体、およびフィトステロールの4-エン-3,6-ジオン体を含む、請求項2に記載の経皮吸収剤。
- フィトステノンはカンペスト-5-エン-3-オンである、請求項1に記載の経皮吸収剤。
- 化粧料である、請求項1~4のいずれか1項に記載の経皮吸収剤。
- 医薬である、請求項1~4のいずれか1項に記載の経皮吸収剤。
- 皮下脂肪を低減するための経皮吸収剤を製造するためのフィトステノンの使用。
- フィトステノンを、皮下脂肪の低減を必要とする対象(ヒトを除く)の皮膚に適用することを含む、対象における皮下脂肪を低減する方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018161943 | 2018-08-30 | ||
JP2018161943 | 2018-08-30 | ||
PCT/JP2019/033822 WO2020045542A1 (ja) | 2018-08-30 | 2019-08-29 | フィトステノンの新規用途 |
Publications (3)
Publication Number | Publication Date |
---|---|
JPWO2020045542A1 JPWO2020045542A1 (ja) | 2021-11-25 |
JPWO2020045542A5 JPWO2020045542A5 (ja) | 2022-09-01 |
JP7389748B2 true JP7389748B2 (ja) | 2023-11-30 |
Family
ID=69643595
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2020539568A Active JP7389748B2 (ja) | 2018-08-30 | 2019-08-29 | フィトステノンの新規用途 |
Country Status (6)
Country | Link |
---|---|
US (1) | US20210177868A1 (ja) |
EP (1) | EP3845232A4 (ja) |
JP (1) | JP7389748B2 (ja) |
KR (1) | KR20210053284A (ja) |
CN (1) | CN112601528A (ja) |
WO (1) | WO2020045542A1 (ja) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001240544A (ja) | 2000-02-29 | 2001-09-04 | Inst Of Physical & Chemical Res | 抗肥満剤及び脂質代謝改善剤 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6531462B2 (en) * | 1997-11-06 | 2003-03-11 | Riken | Medicament for treating obesity and improving lipid metabolism |
CZ20014004A3 (cs) * | 1999-05-17 | 2002-05-15 | The Procter & Gamble Company | Způsoby kosmetické regulace stavu keratinové tkáně savců pomocí místního nanáąení fytosterolových kosmetických přípravků a tyto přípravky |
JP3790686B2 (ja) | 2001-08-03 | 2006-06-28 | 独立行政法人理化学研究所 | 血糖降下剤 |
JP4404710B2 (ja) | 2004-07-14 | 2010-01-27 | 有限会社テクノフローラ | ステロールの5−エン−3−オン体の製造方法、及び分析方法 |
JP2011051939A (ja) | 2009-09-02 | 2011-03-17 | Toyo Hakko:Kk | 血中hdlコレステロール上昇剤、並びにそれを含む飲食品添加剤、飲食品及び医薬 |
WO2011122722A1 (ko) * | 2010-04-01 | 2011-10-06 | 주식회사 벤스랩 | 콜레스테롤 산화효소를 제조하는 방법, 콜레스테롤 산화효소를 이용하여 식물스테롤 발효물을 생산하는 방법, 이 식물스테롤 발효물을 이용한 체지방 개선용 기능성 조성물, 식품 및 건강기능성식품 |
JP6529791B2 (ja) * | 2015-03-11 | 2019-06-12 | 日本メナード化粧品株式会社 | 幹細胞の未分化状態維持剤及び増殖促進剤 |
JP2018161943A (ja) | 2017-03-24 | 2018-10-18 | トヨタ自動車株式会社 | 車両の減速時姿勢制御装置 |
-
2019
- 2019-08-29 WO PCT/JP2019/033822 patent/WO2020045542A1/ja unknown
- 2019-08-29 CN CN201980055505.9A patent/CN112601528A/zh active Pending
- 2019-08-29 JP JP2020539568A patent/JP7389748B2/ja active Active
- 2019-08-29 KR KR1020217005142A patent/KR20210053284A/ko unknown
- 2019-08-29 EP EP19854229.2A patent/EP3845232A4/en active Pending
- 2019-08-29 US US17/269,863 patent/US20210177868A1/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001240544A (ja) | 2000-02-29 | 2001-09-04 | Inst Of Physical & Chemical Res | 抗肥満剤及び脂質代謝改善剤 |
Non-Patent Citations (5)
Title |
---|
BERTI, J. J. et al.,Transcutaneous drug delivery: a practical review,Mayo Clin. Proc.,1995年,Vol.70, No.6,pp.581-586 |
IKEDA, I. et al.,Campest-5-en-3-one, an oxidized derivative of campesterol, activates PPARalpha, promotes energy cons,Biochim. Biophys. Acta,2006年,Vol.1760, No.5,pp.800-807 |
RIBET, C. et al.,Peroxisome proliferator-activated receptor-alpha control of lipid and glucose metabolism in human wh,Endocrinology,2010年,Vol.51, No.1,pp.123-133 |
SUZUKI, K. et al.,A fermentation product of phytosterol including campestenone reduces body fat storage and body w,J. Nutr. Sci. Vitaminol.,2007年,Vol.53, No.1,pp.63-67,ISSN: 0301-4800 |
鈴木 邦夫、他,脂質代謝制御剤(5-カンペステノン),日本臨床,2003年,第61巻, 増刊号6,pp.698-703,ISSN: 0047-1852 |
Also Published As
Publication number | Publication date |
---|---|
JPWO2020045542A1 (ja) | 2021-11-25 |
EP3845232A1 (en) | 2021-07-07 |
US20210177868A1 (en) | 2021-06-17 |
WO2020045542A1 (ja) | 2020-03-05 |
KR20210053284A (ko) | 2021-05-11 |
CN112601528A (zh) | 2021-04-02 |
EP3845232A4 (en) | 2022-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100384412C (zh) | 抑制5α-还原酶活性的方法和组合物 | |
US20180250213A1 (en) | Hair restoration/growth stimulating agent | |
US20070212434A1 (en) | Compositions and methods for human use containing fulvic acid | |
CN101048166A (zh) | 除去异常蛋白质用组合物 | |
EP3064209B1 (en) | Composition comprising ginsenoside f2 for preventing or treating insulin resistance | |
JP2006347952A (ja) | リパーゼ活性化作用を呈するアントラキノン誘導体、それからなる抗肥満薬、食品製剤及び化粧品 | |
TW201116286A (en) | Ceramide production enhancer and moisturizing agent | |
KR102061933B1 (ko) | 세스퀴테르펜 유도체를 유효성분으로 함유하는 근력강화, 근육증강, 근육분화, 근육재생 또는 근감소증 억제효과를 갖는 조성물 | |
CN101791285B (zh) | 一种用于清除面部老年斑的黄皮酰胺复合纳米乳及其制备方法 | |
JP7389748B2 (ja) | フィトステノンの新規用途 | |
JP2011102264A (ja) | アロマターゼ活性化剤 | |
JP2005029483A (ja) | 活性酸素消去剤、並びに化粧料及び飲食物 | |
JP2002241296A (ja) | テストステロン5α−レダクターゼ阻害剤、アンドロゲン受容体結合阻害剤、抗男性ホルモン剤、頭髪化粧料、前立腺肥大抑制剤並びに健康補助食品 | |
JP6371520B2 (ja) | 皮脂合成促進剤 | |
JP5153039B2 (ja) | 抗男性ホルモン剤および頭髪化粧料 | |
TW202112351A (zh) | 局部組成物及其相關方法 | |
JP6002510B2 (ja) | エストロゲン受容体β活性化剤 | |
WO2021153708A1 (ja) | 抗ピロリ菌活性を有するコレステロール類似物質 | |
KR102311011B1 (ko) | 인간지방줄기세포의 증식 촉진용 조성물 | |
US20220088106A1 (en) | Composition comprising cudrania tricuspidate as effective component for alleviating, treating, or preventing muscular diseases, or improving muscule functions | |
JP7455344B2 (ja) | Endo180産生促進剤 | |
JP2021143137A (ja) | 育毛及び/又は発毛用組成物 | |
JP2005281174A (ja) | 活性酸素消去剤 | |
JP3747223B2 (ja) | 活性酸素消去剤 | |
JP2002363085A (ja) | 抗男性ホルモン剤、及び養毛化粧料、皮脂分泌抑制剤並びに前立腺肥大抑制剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AA64 | Notification of invalidation of claim of internal priority (with term) |
Free format text: JAPANESE INTERMEDIATE CODE: A241764 Effective date: 20210601 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210615 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220824 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220824 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230606 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20231031 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20231117 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7389748 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |